폐암 검진 시장 : 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The global lung cancer screening market size is expected to reach USD 10.36 Billion in 2034 from USD 4.57 Billion in 2025, growing at a CAGR of 9.53 during 2026-2034.This market is experiencing significant growth due to the increasing prevalence of lung cancer and the growing emphasis on early detection. Lung cancer remains one of the leading causes of cancer-related deaths worldwide, making screening programs essential for improving survival rates. Advances in imaging technologies, particularly low-dose computed tomography (LDCT), have enhanced the accuracy and accessibility of screening, encouraging more widespread adoption across healthcare systems.

Major drivers include rising awareness about the benefits of early diagnosis, government initiatives promoting cancer screening, and advancements in diagnostic technologies. Healthcare providers are increasingly implementing screening programs for high-risk populations, such as smokers and individuals with a history of lung disease. Additionally, the integration of artificial intelligence in imaging analysis is improving diagnostic accuracy and reducing false positives, further supporting market growth.

Looking ahead, the market is expected to benefit from ongoing research and technological innovation. The development of non-invasive screening methods, such as biomarker-based tests, is likely to expand screening options. Emerging markets are anticipated to offer significant growth opportunities due to improving healthcare infrastructure and awareness. As early detection continues to play a critical role in cancer management, the lung cancer screening market is set for sustained growth.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Cancer Type

• Non-small Cell Lung Cancer (NSCLC)
• Small Cell Lung Cancer

By Diagnosis Type

• Low Dose Spiral CT Scan
• Chest X-ray

By End User

• Hospitals & Clinics
• Diagnostic Centers

COMPANIES PROFILED

• Koninklijke Philips N.V., Siemens Healthineers AG, Canon Medical Systems Corporation, GE Healthcare, FUJIFILM Holdings Corporation, Medtronic, Nuance Communications Inc., Eon, PenRad Technologies Inc., Volpara Solutions Limited

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL LUNG CANCER SCREENING MARKET: BY CANCER TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Cancer Type
• 4.2. Non-small Cell Lung Cancer (NSCLC) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Small Cell Lung Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL LUNG CANCER SCREENING MARKET: BY DIAGNOSIS TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Diagnosis Type
• 5.2. Low Dose Spiral CT Scan Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Chest X-ray Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL LUNG CANCER SCREENING MARKET: BY END USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End User
• 6.2. Hospitals & Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Diagnostic Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL LUNG CANCER SCREENING MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Cancer Type
  • 7.2.2 By Diagnosis Type
  • 7.2.3 By End User
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Cancer Type
  • 7.3.2 By Diagnosis Type
  • 7.3.3 By End User
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Cancer Type
  • 7.4.2 By Diagnosis Type
  • 7.4.3 By End User
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Cancer Type
  • 7.5.2 By Diagnosis Type
  • 7.5.3 By End User
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Cancer Type
  • 7.6.2 By Diagnosis Type
  • 7.6.3 By End User
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL LUNG CANCER SCREENING INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Koninklijke Philips N.V
  • 9.2.2 Siemens Healthineers AG
  • 9.2.3 Canon Medical Systems Corporation
  • 9.2.4 GE Healthcare
  • 9.2.5 FUJIFILM Holdings Corporation
  • 9.2.6 Medtronic
  • 9.2.7 Nuance Communications Inc
  • 9.2.8 Eon
  • 9.2.9 PenRad Technologies Inc
  • 9.2.10 Volpara Solutions Limited